Spondylometaphyseal dysplasia with cone-rod dystrophy
Spondylometaphyseal Dysplasia with Cone-Rod Dystrophy
Spondylometaphyseal dysplasia with cone-rod dystrophy is a rare genetic disorder characterized by skeletal abnormalities and progressive vision loss. This condition is part of a group of disorders known as spondylometaphyseal dysplasias, which affect the spine and the metaphyses of long bones.
Clinical Features[edit | edit source]
Individuals with spondylometaphyseal dysplasia with cone-rod dystrophy typically present with a combination of skeletal and ocular symptoms. The skeletal abnormalities often include short stature, abnormal curvature of the spine (scoliosis or kyphosis), and metaphyseal changes in the long bones. These changes can lead to joint pain and limited mobility.
The ocular component, cone-rod dystrophy, involves the progressive degeneration of the cone and rod photoreceptor cells in the retina. This leads to symptoms such as decreased visual acuity, photophobia, and loss of peripheral vision. Night blindness is also a common feature due to the involvement of rod cells.
Genetics[edit | edit source]
Spondylometaphyseal dysplasia with cone-rod dystrophy is inherited in an autosomal recessive manner. This means that an affected individual must inherit two copies of the mutated gene, one from each parent. The specific gene mutations responsible for this condition have been identified in some cases, but the genetic basis may vary among different families.
Diagnosis[edit | edit source]
Diagnosis of spondylometaphyseal dysplasia with cone-rod dystrophy is based on clinical evaluation, radiographic findings, and genetic testing. Radiographs typically show metaphyseal irregularities and spinal abnormalities. Genetic testing can confirm the diagnosis by identifying mutations in the associated gene.
Management[edit | edit source]
Management of this condition is symptomatic and supportive. Orthopedic interventions may be necessary to address skeletal deformities and improve mobility. Regular ophthalmologic evaluations are important to monitor and manage the progression of cone-rod dystrophy. Low vision aids and other supportive measures can help individuals cope with vision loss.
Prognosis[edit | edit source]
The prognosis for individuals with spondylometaphyseal dysplasia with cone-rod dystrophy varies depending on the severity of the skeletal and ocular manifestations. While skeletal issues can often be managed with appropriate interventions, the progressive nature of cone-rod dystrophy typically leads to significant visual impairment over time.
Related Pages[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Deepika vegiraju, Prab R. Tumpati, MD